Bache, M.; Bernhardt, S.; Passin, S.; Wichmann, H.; Hein, A.; Zschornak, M.P.; Kappler, M.; Taubert, H.; Paschke, R.; Vordermark, D.
Betulinic Acid Derivatives NVX-207 and B10 for Treatment of Glioblastoma—An in Vitro Study of Cytotoxicity and Radiosensitization. Int. J. Mol. Sci. 2014, 15, 19777-19790.
https://doi.org/10.3390/ijms151119777
AMA Style
Bache M, Bernhardt S, Passin S, Wichmann H, Hein A, Zschornak MP, Kappler M, Taubert H, Paschke R, Vordermark D.
Betulinic Acid Derivatives NVX-207 and B10 for Treatment of Glioblastoma—An in Vitro Study of Cytotoxicity and Radiosensitization. International Journal of Molecular Sciences. 2014; 15(11):19777-19790.
https://doi.org/10.3390/ijms151119777
Chicago/Turabian Style
Bache, Matthias, Stephan Bernhardt, Sarina Passin, Henri Wichmann, Anja Hein, Martin P Zschornak, Matthias Kappler, Helge Taubert, Reinhard Paschke, and Dirk Vordermark.
2014. "Betulinic Acid Derivatives NVX-207 and B10 for Treatment of Glioblastoma—An in Vitro Study of Cytotoxicity and Radiosensitization" International Journal of Molecular Sciences 15, no. 11: 19777-19790.
https://doi.org/10.3390/ijms151119777
APA Style
Bache, M., Bernhardt, S., Passin, S., Wichmann, H., Hein, A., Zschornak, M. P., Kappler, M., Taubert, H., Paschke, R., & Vordermark, D.
(2014). Betulinic Acid Derivatives NVX-207 and B10 for Treatment of Glioblastoma—An in Vitro Study of Cytotoxicity and Radiosensitization. International Journal of Molecular Sciences, 15(11), 19777-19790.
https://doi.org/10.3390/ijms151119777
